Figure 4From: Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Immunosuppressive treatment regimen. Basiliximab will be applied on days 1 and 5 after transplantation; 2 g mycophenolic acid (MPA) will be applied per day given as a split dose. Steroids will be started on postoperative day 1 and tapered by month 6 after liver transplantation, MAPC infusions will be administered into the portal vein during transplantation and later intravenously on day 3.Back to article page